Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Abortive Treatment of Migraine With the Cefaly® Abortive Program Device: Pilot Trial

NCT03217968 is registered in ClinicalTrials.gov with Cefaly Technology as lead sponsor.

NCT NCT03217968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03217968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Abortive Treatment of Migraine With the Cefaly® Abortive Program Device: Pilot Trial
Lead sponsor
Cefaly Technology
Phase
Not applicable
Overall status
Completed
Start date
August 10, 2017
Completion date
January 10, 2018
Enrollment
59 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine